Glenmede Trust CO Na Enanta Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $18,110 - $20,886	-440 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.36 - $53.53 $867 - $1,070	20 Added 4.76%	440 $20,000
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $14,189 - $17,619	306 Added 268.42%	420 $21,000
Q4 2019 Feb 12, 2020	SELL	$57.95 - $66.61 $3,824 - $4,396	-66 Reduced 36.67%	114 $7,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $420 - $617	7 Added 4.05%	180 $9,000
Q2 2019 Aug 13, 2019	BUY	$81.3 - $97.35 $9,430 - $11,292	116 Added 203.51%	173 $13,000
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $1,046 - $1,354	16 Added 39.02%	57 $4,000
Q2 2018 Aug 15, 2018	BUY	$81.85 - $120.51 $3,355 - $4,940	41 New	41 $5,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.